ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 643006 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 643006; 2) Community: the network communities that were significantly associated with the response to NSC 643006; 3) Molecule: the relationships between components within communities and NSC 643006; 4) MDR: the compounds that were significantly associated with the NSC 643006.

NSC Compound Enrichment Correlation
NSC 720447 Null 0.00265144454581183 -0.15213242
NSC 733504 Everolimus 0.00265144454581183 0.027749746
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00265144454581183 0.18480874
NSC 644961 Null 0.00286159651545682 0.72907036
NSC 648114 ANTINEOPLASTIC-D648114 0.00286159651545682 0.57767142
NSC 691767 Null 0.00286159651545682 -0.026581747
NSC 693765 Null 0.00286159651545682 0.10365225
NSC 728317 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}butane Bis(trifluoroacetate) 0.00286159651545682 0.45177101
NSC 107124 Camptothecin Derivative 0.00286159651545688 0.45657976
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.00286159651545688 0.34536778
Total:84  Current:7    [First] [Prev] [Next] [Last]